Lv31
362 积分 2025-03-19 加入
Novel antisense inhibition of diacylglycerol O-acyltransferase 2 for treatment of non-alcoholic fatty liver disease: a multicentre, double-blind, randomised, placebo-controlled phase 2 trial
1小时前
待确认
Polycystic ovary syndrome: A metabolic disorder with therapeutic opportunities
11天前
已完结
Inducing and Characterizing Vesicular Steatosis in Differentiated HepaRG Cells
1个月前
已完结
Relating protein pharmacology by ligand chemistry
2个月前
已完结
Nobiletin mitigates NAFLD via lipophagy and inflammation
3个月前
已完结
Nobiletin Ameliorates Hepatic Lipid Deposition, Oxidative Stress, and Inflammation by Mechanisms That Involve the Nrf2/NF-κB Axis in Nonalcoholic Fatty Liver Disease
3个月前
已完结
Nobiletin Ameliorates Hepatic Lipid Deposition, Oxidative Stress, and Inflammation by Mechanisms That Involve the Nrf2/NF-κB Axis in Nonalcoholic Fatty Liver Disease
3个月前
已完结
Nobiletin Ameliorates Nonalcoholic Fatty Liver Disease by Regulating Gut Microbiota and Myristoleic Acid Metabolism
3个月前
已完结
Inhibition of PTP1B by isosinensetin, a polymethoxylated flavone isolated from trifoliate orange peel: kinetic studies, molecular docking, and molecular dynamics simulation
3个月前
已完结
皖公网安备34019202002308
